The Clorox Company (NYSE:CLX) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lifted its position in The Clorox Company (NYSE:CLX) by 1.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 723,906 shares of the company’s stock after purchasing an additional 13,038 shares during the period. Charles Schwab Investment Management Inc. owned about 0.58% of Clorox worth $117,932,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Mizuho Securities USA LLC raised its position in shares of Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the period. Nuance Investments LLC raised its holdings in Clorox by 150.6% in the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares during the period. Van ECK Associates Corp boosted its position in Clorox by 2.2% during the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after purchasing an additional 31,510 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in Clorox by 14.4% in the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock valued at $131,200,000 after purchasing an additional 120,716 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of Clorox by 11.9% in the second quarter. Dimensional Fund Advisors LP now owns 802,237 shares of the company’s stock valued at $109,483,000 after buying an additional 85,529 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CLX has been the topic of a number of research analyst reports. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and lifted their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. DA Davidson upped their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Evercore ISI lowered their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Finally, Barclays boosted their price objective on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research note on Friday, November 1st. Five analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $155.00.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.57% of the company’s stock.

Clorox Stock Down 1.8 %

NYSE CLX opened at $166.32 on Tuesday. The business’s fifty day simple moving average is $162.79 and its 200-day simple moving average is $148.71. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a market cap of $20.59 billion, a PE ratio of 57.95, a P/E/G ratio of 3.13 and a beta of 0.41. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.35.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.49 earnings per share. As a group, equities analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 2.93%. Clorox’s dividend payout ratio is currently 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.